Distinguished in Cerebral Hypoxia

Dr. Dustin R. Fraidenburg

Pulmonary Medicine | Intensive Care Medicine
The Board Of Trustees Of The University Of Illinois
840 S Wood St Mc, 787 Uic Medicine, 
Chicago, IL 
Accepting New Patients
Offers Telehealth
16 Years of Experience
Distinguished in Cerebral Hypoxia
The Board Of Trustees Of The University Of Illinois
840 S Wood St Mc, 787 Uic Medicine, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dustin Fraidenburg is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Chicago, Illinois. Dr. Fraidenburg has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Pulmonary Hypertension, Cerebral Hypoxia, Pulmonary Veno-Occlusive Disease, and Systemic Sclerosis (SSc). Dr. Fraidenburg is currently accepting new patients.

His clinical research consists of co-authoring 32 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Cerebral Hypoxia.

Graduate Institution
Wayne State University School Of Medicine, 2009
Specialties
Pulmonary Medicine
Intensive Care Medicine
Licenses
Internal Medicine in IL
Hospital Affiliations
University Of Illinois Hospital And Clinics
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 7 Less Insurance Carriers -

Locations

THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
840 S Wood St Mc, 787 Uic Medicine, Chicago, IL 60612

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
Enrollment Status: Terminated
Publish Date: December 09, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

32 Total Publications

Important Differences in Disease Severity, Echocardiography Findings, and Referral Delays in Non-Hispanic Black Patients With Pulmonary Arterial Hypertension.
Important Differences in Disease Severity, Echocardiography Findings, and Referral Delays in Non-Hispanic Black Patients With Pulmonary Arterial Hypertension.
Journal: Pulmonary circulation
Published: March 13, 2025
Similar Doctors
Jacob I. Sznajder
Distinguished in Cerebral Hypoxia
Dr. Jacob I. Sznajder
Pulmonary Medicine
Distinguished in Cerebral Hypoxia
Dr. Jacob I. Sznajder
Pulmonary Medicine
676 N St Clair St Ste 2100, Arkes Pavilion, 
Chicago, IL 
 (4.0 miles away)
312-695-1800
Experience:
47+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jacob Sznajder is a Pulmonary Medicine provider in Chicago, Illinois. Dr. Sznajder has been practicing medicine for over 47 years and is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Cerebral Hypoxia, Pneumonia, Acute Respiratory Distress Syndrome (ARDS), and Long Haul COVID.

Distinguished in Cerebral Hypoxia
Dr. John E. Pantano
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Cerebral Hypoxia
Dr. John E. Pantano
Pulmonary Medicine | Intensive Care Medicine

Endeavor Health Medical Group

455 S Roselle Rd, 
Schaumburg, IL 
 (22.3 miles away)
847-985-0600
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

John Pantano is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Schaumburg, Illinois. Dr. Pantano is rated as a Distinguished provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Lung Metastases, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Chronic Obstructive Pulmonary Disease (COPD). Dr. Pantano is currently accepting new patients.

Distinguished in Cerebral Hypoxia
Dr. Shashi K. Bellam
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Cerebral Hypoxia
Dr. Shashi K. Bellam
Pulmonary Medicine | Intensive Care Medicine

Endeavor Health Medical Group

2100 Pfingsten Rd, 
Glenview, IL 
 (16.8 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Shashi Bellam is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Glenview, Illinois. Dr. Bellam is rated as a Distinguished provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, and Pacemaker Implantation. Dr. Bellam is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fraidenburg's expertise for a condition
ConditionClose
View All 13 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile